The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is a bilateral clinical research partnership formed in 2010 between the goverments of Indonesia and the United States.

Guided by the Directorate General of Advanced Health (Keslan), Ministry of Health of the Republic of Indonesia, and the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH), INA-RESPOND conducts high quality infectious diseases research through a national network of hospitals, laboratories, and research institutions.

The vision of INA-RESPOND is to be a leading infectious disease clinical research group that minimizes the impact of outbreaks and improves the health of people in Indonesia, the United States, and the world.

About Us

About INA-RESPOND
Read More
Research

INA-RESPOND's Research
Read more
Latest Article

INA-RESPOND's latest article
Read more

INA-RESPOND at a Glance

COLLABORATORS

14 national and international collaborators

STUDIES

11 multicenter studies, including observational studies and randomized controlled trials

HOSPITALS

19 hospitals across Indonesia, with access to healthcare institutions nationwide

PATHOGENS

Laboratory capacity to study 60+ pathogens

SPECIMENS

300.000+ research specimens managed

PUBLICATIONS

40 international scientific publications

How to Collaborate with INA-RESPOND

Click Here

About Us

Research

Latest Article

How to Collaborate with INA-RESPOND

Latest Articles

Latest Publications

About Us

Research

Latest Article

How to Collaborate with INA-RESPOND

Latest Articles

Latest Publications

INA-RESPOND Secretariat

Follow Us